PCS-499

N/A

Report date: 2025/02/25 20:00:09
NME

Base Information

Drug NamePCS-499
Drug Alias NameCTP-499PCS-499
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action3',5'-cyclic phosphodiesterase inhibitors
Targets3',5'-cyclic phosphodiesterase
Therapy Area/IndicationsDiabetes Mellitus, Type 2Necrobiosis LipoidicaRenal Insufficiency, Chronic +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesConcert
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesConcert Pharmaceuticals IncProcessa Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2Necrobiosis LipoidicaRenal Insufficiency, Chronic +[4] 

Other Information

ATC CodeN/A
Related LinksN/A